Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research
- PMID: 9467791
Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research
Similar articles
-
The Addiction Severity Index in clinical efficacy trials of medications for cocaine dependence.NIDA Res Monogr. 1997;175:182-91. NIDA Res Monogr. 1997. PMID: 9467798 Review.
-
Outcome measurement considerations: pharmacological treatments for substance abuse.NIDA Res Monogr. 1997;175:118-36. NIDA Res Monogr. 1997. PMID: 9467795 Review. No abstract available.
-
Management of clinical trials with new medications for cocaine dependence and abuse.NIDA Res Monogr. 1997;175:96-117. NIDA Res Monogr. 1997. PMID: 9467794 Review.
-
Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials.NIDA Res Monogr. 1997;175:137-57. NIDA Res Monogr. 1997. PMID: 9467796 Review.
-
Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective.NIDA Res Monogr. 1997;175:73-95. NIDA Res Monogr. 1997. PMID: 9467793 Review.
Cited by
-
Effects of perceived cocaine availability on subjective and objective responses to the drug.Subst Abuse Treat Prev Policy. 2007 Oct 11;2:30. doi: 10.1186/1747-597X-2-30. Subst Abuse Treat Prev Policy. 2007. PMID: 17931408 Free PMC article. Clinical Trial.
-
Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcer.J Pharmacol Exp Ther. 2009 Jun;329(3):1084-90. doi: 10.1124/jpet.109.151357. Epub 2009 Mar 3. J Pharmacol Exp Ther. 2009. PMID: 19258516 Free PMC article.
-
Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans.Psychopharmacology (Berl). 2004 Feb;171(4):441-9. doi: 10.1007/s00213-003-1598-4. Epub 2003 Sep 19. Psychopharmacology (Berl). 2004. PMID: 14504683 Clinical Trial.